Compare · MD vs PACS
MD vs PACS
Side-by-side comparison of Pediatrix Medical Group Inc. (MD) and PACS Group Inc. (PACS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MD and PACS operate in Hospital/Nursing Management (Health Care), so they compete in similar markets.
- PACS is the larger of the two at $7.11B, about 3.6x MD ($1.98B).
- Over the past year, MD is up 88.8% and PACS is up 260.5% - PACS leads by 171.8 points.
- PACS has been more active in the news (11 items in the past 4 weeks vs 3 for MD).
- MD has more recent analyst coverage (9 ratings vs 6 for PACS).
- Company
- Pediatrix Medical Group Inc.
- PACS Group Inc.
- Price
- $24.18-7.29%
- $44.92+3.79%
- Market cap
- $1.98B
- $7.11B
- 1M return
- +0.00%
- +29.27%
- 1Y return
- +88.76%
- +260.51%
- Industry
- Hospital/Nursing Management
- Hospital/Nursing Management
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- News (4w)
- 3
- 11
- Recent ratings
- 9
- 6
Pediatrix Medical Group Inc.
MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of March 16, 2021, it operated a network of approximately 2,300 physicians. The company was founded in 1979 and is based in Sunrise, Florida.
Latest MD
- SEC Form SCHEDULE 13G filed by Pediatrix Medical Group Inc.
- EVP, GC & Corp Sec Haddock David was granted 20,036 shares (SEC Form 4)
- SEC Form 3 filed by new insider Haddock David
- EVP, GC, Chief Admin Off & Sec Moore Mary Ann E gifted 18,407 shares and received a gift of 18,407 shares, decreasing direct ownership by 19% to 78,059 units (SEC Form 4)
- EVP, CFO and Treasurer Rossi Kasandra H was granted 31,800 shares and covered exercise/tax liability with 3,701 shares, increasing direct ownership by 38% to 101,399 units (SEC Form 4)
- Chief Executive Officer Ordan Mark S was granted 224,372 shares, covered exercise/tax liability with 19,119 shares and returned 97,174 shares to the company, increasing direct ownership by 36% to 410,884 units (SEC Form 4)
- EVP, Chief Invest & Strategy Neeb Don Gregory covered exercise/tax liability with 8,003 shares and was granted 63,888 shares, increasing direct ownership by 69% to 137,231 units (SEC Form 4)
- EVP, GC, Chief Admin Off & Sec Moore Mary Ann E covered exercise/tax liability with 11,944 shares, decreasing direct ownership by 11% to 96,466 units (SEC Form 4)
- Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology
- SEC Form S-8 filed by Pediatrix Medical Group Inc.
Latest PACS
- Director Hancock Mark sold $1,140,393 worth of shares (25,304 units at $45.07) as part of a pre-agreed trading plan, decreasing direct ownership by 0.05% to 53,920,512 units (SEC Form 4)
- Chief Accounting Officer Lewis Michelle Renee sold $675,424 worth of shares (15,000 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 355,338 units (SEC Form 4)
- Director Hancock Mark was granted 4,287 shares and sold $7,295,867 worth of shares (161,068 units at $45.30) as part of a pre-agreed trading plan, decreasing direct ownership by 0.29% to 53,945,816 units (SEC Form 4)
- Director Conway Patrick Hugh was granted 4,287 shares, increasing direct ownership by 53% to 12,444 units (SEC Form 4)
- Director Millard Jacqueline was granted 4,287 shares, increasing direct ownership by 27% to 20,217 units (SEC Form 4)
- Director Leavitt Taylor S. was granted 4,287 shares, increasing direct ownership by 28% to 19,784 units (SEC Form 4)
- Director Dilsaver Evelyn S was granted 4,287 shares, increasing direct ownership by 13% to 36,085 units (SEC Form 4)
- PACS Group to Acquire Operations of 34 Facilities Across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah
- Co Fndr; Exec V Chair Hancock Mark sold $8,075,787 worth of shares (200,000 units at $40.38) as part of a pre-agreed trading plan, decreasing direct ownership by 0.37% to 54,102,597 units (SEC Form 4)
- Chief Accounting Officer Lewis Michelle Renee sold $600,178 worth of shares (15,000 units at $40.01) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 370,338 units (SEC Form 4)